Incruse Ellipta vs. Spiriva HandiHaler
Are Incruse Ellipta and Spiriva HandiHaler the Same Thing?
Incruse Ellipta (umeclidinium) Inhalation Powder and Spiriva HandiHaler (tiotropium bromide) Inhalation Powder are anticholinergic drugs used for prevention and maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.
Side effects of Incruse Ellipta and Spiriva HandiHaler that are similar include cold symptoms (stuffy nose, sneezing, cough, sore throat), muscle pain, stomach pain or upset, and constipation.
Side effects of Incruse Ellipta that are different from Spiriva HandiHaler include upper respiratory infection, joint pain, tooth pain, bruising or dark areas of skin, chest pain, and fast or irregular heartbeat.
Side effects of Spiriva HandiHaler that are different from Incruse Ellipta include dry mouth, vomiting, and nosebleed.
Both Incruse Ellipta and Spiriva HandiHaler may interact with other anticholinergic drugs.
Spiriva HandiHaler may also interact with belladonna, cimetidine, hyoscyamine, mepenzolate, methantheline, and scopolamine.
What Are Possible Side Effects of Incruse Ellipta?
Common side effects of Incruse Ellipta include:
- upper respiratory infection,
- stuffy or runny nose,
- cough,
- sore throat,
- joint pain,
- muscle pain,
- tooth pain,
- stomach pain,
- bruising or dark areas of skin,
- chest pain,
- fast or irregular heartbeat, and
- constipation.
What Are Possible Side Effects of Spiriva HandiHaler?
Common side effects of Spiriva HandiHaler include:
- dry mouth,
- constipation,
- upset stomach,
- vomiting,
- cold symptoms (stuffy nose, sneezing, sore throat),
- nosebleed, or
- muscle pain.
Tell your doctor if you have any serious side effects of Spiriva HandiHaler including:
- difficult or painful urination, or
- fast heartbeat.
What Is Incruse Ellipta?
Incruse Ellipta (umeclidinium) Inhalation Powder is an anticholinergic drug used for the long-term, once-daily, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.
What Is Spiriva HandiHaler?
Spiriva HandiHaler (tiotropium bromide) Inhalation Powder is an anticholinergic drug used to prevent bronchospasm (narrowing of the airways in the lungs) in people with bronchitis, emphysema, or COPD (chronic obstructive pulmonary disease).
What Drugs Interact With Incruse Ellipta?
Incruse Ellipta may interact with other anticholinergic drugs. Tell your doctor all medications and supplements you use. During pregnancy, Incruse Ellipta should be taken only if prescribed. It is unknown if this drug passes into breast milk. Consult your doctor before breastfeeding.
What Drugs Interact With Spiriva HandiHaler?
Spiriva may interact with atropine, belladonna, cimetidine, clidinium, dicyclomine, glycopyrrolate, hyoscyamine, mepenzolate, methantheline, methscopolamine, propantheline, or scopolamine. Tell your doctor all medications you use. During pregnancy, Spiriva should be used only when prescribed. It is unknown if this medication passes into breast milk. Consult your doctor before breastfeeding.
How Should Incruse Ellipta be Taken?
Incruse Ellipta (umeclidinium 62.5 mcg) should be administered as 1 inhalation dose once daily by the orally inhaled route only. Incruse Ellipta may interact with other anticholinergic drugs. Tell your doctor all medications and supplements you use.
How Should Spiriva HandiHaler be Taken?
The recommended dose of Spiriva HandiHaler is two inhalations of the powder contents of one Spiriva capsule, once-daily, with the HandiHaler device.